Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

7 Penny Stocks That Could Have an Explosive Year-End

By Thomas Niel, InvestorPlace Contributor

While meme trends are on the wane, these seven penny stocks still stand to make turbocharged moves higher in the short-term.

The Novavax Rebound Is Just Warming Up

By Thomas Niel, InvestorPlace Contributor

Still likely to see high volatility, if you can't handle the wild swings you may want to look elsewhere. But if you're looking for a vaccine play where the upside potential is crystal clear? NVAX remains your best choice.

Wait for Opportune Weakness Before Buying Sundial Growers

By Thomas Niel, InvestorPlace Contributor

At some point down the road, SNDL stock could fall to a more opportune entry point. Unfortunately, though, now is not that time.

Many Factors Could Still Sink Palantir Stock

By Thomas Niel, InvestorPlace Contributor

As Palantir's risk continues to vastly exceed its near-term potential gains, steering clear of PLTR stock remains your best move.

Another Spike for Shiba Inu Seems Unlikely, But Possible

By Thomas Niel, InvestorPlace Contributor

With its run-up in price unprecedented, and its next move tough to predict? The best approach with Shiba Inu remains the same. Only invest what you can afford to lose into it.

7 Retail Stocks That Will Be Six Feet Under in 2022

By Thomas Niel, InvestorPlace Contributor

Facing many challenges, expect these seven retail stocks to experience to a big drop in price over the next twelve months.

Vinco Ventures May Be a Buy as the Redditors Appear to Be Packing It In

By Thomas Niel, InvestorPlace Contributor

Continue to view BBIG stock with a critical eye. But keep it on your radar, as more information and a lower stock price could make it worthwhile buy.

Buy SAVA Stock on Dips as its Phase 3 Trial Moves Along

By Thomas Niel, InvestorPlace Contributor

There's no way to mitigate its high risk nature completely. But if you're bullish on Simulfilam? Buying SAVA stock on weakness, between now and when the data from its Phase 3 trial starts rolling in, may be the best move.

Why a Wait-and-See Approach May Not Work With ContextLogic Stock

By Thomas Niel, InvestorPlace Contributor

Investors who wait for evidence ContextLogic's turnaround is successful may find it's too late to buy WISH stock.

7 Meme Stocks to Avoid Like the Plague

By Thomas Niel, InvestorPlace Contributor

Retail investors are dropping out of these meme stocks and the hype is fading. These shares are unlikely to reach previous highs again.

Load More